P616Cardioprotective effects of nanoemulsions loaded with natural anti-inflammatory molecules against doxorubicin-induced cardiotoxicity in cardiomyocytes

Cardiotoxicity is one of the most significant adverse effects of the oncologic treatment with doxorubicin, which is responsible for a substantial morbid and mortality. Small molecules derived from medicinal plants with anti-inflammatory properties could have cardioprotective activites so potentially used in cardio-oncology management. Nanomedicine offer a new pharmacological tool able to increase bioavailability and protect natural bioactives with antiinflammatory and cardioprotective action.